 Sara Sawyer
Concepts (595)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Primates | 19 | 2024 | 124 | 3.950 |
Why?
| | Evolution, Molecular | 17 | 2021 | 488 | 3.910 |
Why?
| | Virus Replication | 15 | 2025 | 479 | 2.780 |
Why?
| | CD4 Antigens | 6 | 2025 | 141 | 2.750 |
Why?
| | Selection, Genetic | 18 | 2021 | 262 | 2.720 |
Why?
| | Viruses | 6 | 2023 | 112 | 2.680 |
Why?
| | HIV-1 | 12 | 2024 | 857 | 2.490 |
Why?
| | Dengue Virus | 3 | 2025 | 48 | 2.300 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 3 | 2025 | 85 | 2.030 |
Why?
| | Pan troglodytes | 5 | 2025 | 61 | 1.950 |
Why?
| | Mutation | 27 | 2023 | 3953 | 1.810 |
Why?
| | Exome | 10 | 2023 | 231 | 1.780 |
Why?
| | Simian Immunodeficiency Virus | 3 | 2025 | 87 | 1.640 |
Why?
| | Host-Pathogen Interactions | 9 | 2021 | 364 | 1.600 |
Why?
| | Saliva | 3 | 2023 | 241 | 1.530 |
Why?
| | Ubiquitin-Protein Ligases | 10 | 2019 | 176 | 1.470 |
Why?
| | Nuclear Proteins | 10 | 2020 | 710 | 1.460 |
Why?
| | Carrier Proteins | 11 | 2017 | 768 | 1.440 |
Why?
| | Carrier State | 2 | 2021 | 65 | 1.370 |
Why?
| | Viral Proteins | 7 | 2021 | 343 | 1.330 |
Why?
| | Receptors, Virus | 6 | 2019 | 83 | 1.310 |
Why?
| | Sequence Analysis, DNA | 11 | 2024 | 811 | 1.310 |
Why?
| | Host Specificity | 5 | 2018 | 26 | 1.310 |
Why?
| | Zoonoses | 3 | 2019 | 32 | 1.280 |
Why?
| | Animals | 58 | 2025 | 36768 | 1.190 |
Why?
| | Dengue | 3 | 2025 | 77 | 1.160 |
Why?
| | Nuclear Pore Complex Proteins | 2 | 2018 | 37 | 1.150 |
Why?
| | Genes, BRCA1 | 5 | 2015 | 38 | 1.140 |
Why?
| | Genomics | 8 | 2025 | 790 | 1.080 |
Why?
| | Saccharomyces cerevisiae | 6 | 2018 | 558 | 1.080 |
Why?
| | Virology | 2 | 2024 | 25 | 1.070 |
Why?
| | Intellectual Disability | 8 | 2024 | 163 | 1.060 |
Why?
| | Tripartite Motif Proteins | 7 | 2019 | 41 | 1.040 |
Why?
| | Genome | 3 | 2024 | 291 | 1.030 |
Why?
| | Receptors, Transferrin | 3 | 2015 | 24 | 1.000 |
Why?
| | Chiroptera | 3 | 2019 | 55 | 0.980 |
Why?
| | Reverse Genetics | 1 | 2025 | 4 | 0.960 |
Why?
| | Flaviviridae | 1 | 2025 | 7 | 0.960 |
Why?
| | Influenza A Virus, H3N2 Subtype | 2 | 2023 | 46 | 0.950 |
Why?
| | Gorilla gorilla | 1 | 2025 | 22 | 0.940 |
Why?
| | Virus Internalization | 5 | 2022 | 47 | 0.940 |
Why?
| | Biological Evolution | 7 | 2024 | 464 | 0.920 |
Why?
| | Rare Diseases | 5 | 2025 | 101 | 0.900 |
Why?
| | Amino Acid Sequence | 20 | 2019 | 2145 | 0.900 |
Why?
| | HIV Infections | 9 | 2019 | 2812 | 0.860 |
Why?
| | Saccharomyces cerevisiae Proteins | 6 | 2018 | 404 | 0.850 |
Why?
| | Orthomyxoviridae | 1 | 2024 | 42 | 0.850 |
Why?
| | Polymorphism, Single Nucleotide | 14 | 2019 | 2190 | 0.840 |
Why?
| | Peptide Hydrolases | 3 | 2020 | 111 | 0.840 |
Why?
| | Humans | 104 | 2025 | 136783 | 0.830 |
Why?
| | Influenza in Birds | 1 | 2023 | 3 | 0.830 |
Why?
| | Retroelements | 2 | 2018 | 47 | 0.830 |
Why?
| | Repressor Proteins | 7 | 2023 | 424 | 0.820 |
Why?
| | Arterivirus | 1 | 2022 | 2 | 0.800 |
Why?
| | Hemorrhagic Fevers, Viral | 1 | 2022 | 6 | 0.800 |
Why?
| | Dog Diseases | 2 | 2023 | 62 | 0.800 |
Why?
| | Epidemiological Monitoring | 1 | 2023 | 60 | 0.790 |
Why?
| | Cell Cycle Proteins | 5 | 2016 | 611 | 0.780 |
Why?
| | Neurofibromatosis 1 | 1 | 2023 | 52 | 0.780 |
Why?
| | Virus Diseases | 2 | 2016 | 214 | 0.770 |
Why?
| | High-Throughput Nucleotide Sequencing | 7 | 2019 | 535 | 0.760 |
Why?
| | Rhabdomyosarcoma | 1 | 2023 | 72 | 0.750 |
Why?
| | Phylogeny | 12 | 2019 | 896 | 0.740 |
Why?
| | Genetic Testing | 7 | 2025 | 452 | 0.730 |
Why?
| | Homozygote | 3 | 2021 | 203 | 0.730 |
Why?
| | RNA, Viral | 5 | 2021 | 651 | 0.730 |
Why?
| | Genetic Variation | 8 | 2018 | 985 | 0.730 |
Why?
| | RNA, Messenger | 5 | 2023 | 2831 | 0.720 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2024 | 250 | 0.700 |
Why?
| | Mammals | 5 | 2024 | 283 | 0.690 |
Why?
| | Congenital Abnormalities | 1 | 2021 | 88 | 0.690 |
Why?
| | Cell Line | 11 | 2025 | 2836 | 0.680 |
Why?
| | Urogenital Abnormalities | 1 | 2021 | 64 | 0.680 |
Why?
| | Aotidae | 3 | 2019 | 7 | 0.680 |
Why?
| | Molecular Sequence Data | 18 | 2015 | 2903 | 0.680 |
Why?
| | Wnt Proteins | 1 | 2021 | 133 | 0.670 |
Why?
| | Interferon Type I | 1 | 2021 | 141 | 0.670 |
Why?
| | Herpesvirus 1, Human | 3 | 2018 | 85 | 0.650 |
Why?
| | Genome, Viral | 3 | 2025 | 144 | 0.640 |
Why?
| | Viral Tropism | 2 | 2024 | 30 | 0.630 |
Why?
| | Soft Tissue Neoplasms | 2 | 2018 | 114 | 0.630 |
Why?
| | Computational Biology | 7 | 2020 | 645 | 0.630 |
Why?
| | Species Specificity | 9 | 2018 | 584 | 0.630 |
Why?
| | Membrane Proteins | 3 | 2018 | 1162 | 0.620 |
Why?
| | Virus Attachment | 2 | 2015 | 16 | 0.610 |
Why?
| | Polysaccharides | 1 | 2019 | 84 | 0.610 |
Why?
| | Genes, BRCA2 | 4 | 2015 | 29 | 0.600 |
Why?
| | Arenaviruses, New World | 2 | 2015 | 3 | 0.600 |
Why?
| | DNA-Binding Proteins | 8 | 2021 | 1500 | 0.600 |
Why?
| | Genes | 2 | 2015 | 230 | 0.580 |
Why?
| | Genetic Diseases, Inborn | 2 | 2015 | 42 | 0.580 |
Why?
| | HEK293 Cells | 7 | 2024 | 728 | 0.580 |
Why?
| | Transcription Factors | 4 | 2023 | 1714 | 0.570 |
Why?
| | Hamartoma Syndrome, Multiple | 1 | 2017 | 12 | 0.570 |
Why?
| | Leukoencephalopathies | 1 | 2017 | 21 | 0.560 |
Why?
| | Base Sequence | 12 | 2024 | 2180 | 0.560 |
Why?
| | Circulating Tumor DNA | 3 | 2022 | 34 | 0.560 |
Why?
| | BRCA1 Protein | 2 | 2014 | 76 | 0.550 |
Why?
| | DNA, Circular | 2 | 2014 | 15 | 0.540 |
Why?
| | Kidney Diseases | 1 | 2021 | 406 | 0.540 |
Why?
| | Fibroma | 1 | 2017 | 22 | 0.540 |
Why?
| | Lung Diseases, Interstitial | 1 | 2023 | 634 | 0.530 |
Why?
| | Neurodevelopmental Disorders | 4 | 2024 | 177 | 0.530 |
Why?
| | DNA Repair Enzymes | 1 | 2016 | 28 | 0.510 |
Why?
| | Ribonucleoproteins | 1 | 2017 | 105 | 0.510 |
Why?
| | Immediate-Early Proteins | 1 | 2016 | 49 | 0.510 |
Why?
| | Models, Biological | 1 | 2024 | 1769 | 0.510 |
Why?
| | PTEN Phosphohydrolase | 1 | 2017 | 162 | 0.510 |
Why?
| | Influenza A virus | 4 | 2023 | 109 | 0.510 |
Why?
| | Molecular Chaperones | 1 | 2018 | 195 | 0.500 |
Why?
| | Exoribonucleases | 1 | 2016 | 49 | 0.500 |
Why?
| | Kidney | 2 | 2021 | 1463 | 0.500 |
Why?
| | Macrophages | 1 | 2024 | 1541 | 0.500 |
Why?
| | Virus Physiological Phenomena | 2 | 2012 | 6 | 0.490 |
Why?
| | Lipomatosis, Multiple Symmetrical | 1 | 2015 | 1 | 0.480 |
Why?
| | Genetic Predisposition to Disease | 10 | 2020 | 2417 | 0.480 |
Why?
| | Host-Parasite Interactions | 1 | 2016 | 106 | 0.480 |
Why?
| | Dogs | 5 | 2023 | 409 | 0.480 |
Why?
| | Abnormalities, Multiple | 4 | 2024 | 189 | 0.470 |
Why?
| | Fanconi Anemia | 1 | 2014 | 11 | 0.460 |
Why?
| | Breast Neoplasms | 6 | 2015 | 2239 | 0.460 |
Why?
| | GTP Phosphohydrolases | 1 | 2015 | 92 | 0.460 |
Why?
| | Fungal Proteins | 3 | 2006 | 134 | 0.460 |
Why?
| | DNA Repair | 3 | 2014 | 230 | 0.450 |
Why?
| | Histones | 2 | 2017 | 635 | 0.450 |
Why?
| | Multigene Family | 2 | 2013 | 199 | 0.450 |
Why?
| | Recombination, Genetic | 3 | 2013 | 198 | 0.450 |
Why?
| | Embryonic Development | 1 | 2015 | 118 | 0.450 |
Why?
| | Retroviridae | 5 | 2011 | 99 | 0.440 |
Why?
| | Genome, Human | 7 | 2020 | 424 | 0.440 |
Why?
| | BRCA2 Protein | 1 | 2014 | 63 | 0.430 |
Why?
| | Cerebellar Ataxia | 1 | 2014 | 10 | 0.430 |
Why?
| | Peptidyl-Dipeptidase A | 2 | 2022 | 52 | 0.430 |
Why?
| | Polymorphism, Genetic | 6 | 2014 | 657 | 0.420 |
Why?
| | Ranavirus | 1 | 2013 | 6 | 0.420 |
Why?
| | Cutis Laxa | 1 | 2013 | 2 | 0.420 |
Why?
| | Elastic Tissue | 1 | 2013 | 9 | 0.410 |
Why?
| | Genes, Essential | 1 | 2013 | 22 | 0.410 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2015 | 234 | 0.410 |
Why?
| | Proteins | 3 | 2016 | 1009 | 0.410 |
Why?
| | Ovarian Neoplasms | 5 | 2022 | 563 | 0.400 |
Why?
| | Mitochondrial Proteins | 1 | 2015 | 256 | 0.400 |
Why?
| | Exons | 4 | 2024 | 349 | 0.400 |
Why?
| | Genome, Fungal | 2 | 2018 | 41 | 0.400 |
Why?
| | Transcriptome | 1 | 2019 | 971 | 0.400 |
Why?
| | Antigens, CD | 1 | 2015 | 522 | 0.390 |
Why?
| | Nervous System Diseases | 1 | 2015 | 265 | 0.380 |
Why?
| | Plasmodium knowlesi | 1 | 2011 | 1 | 0.370 |
Why?
| | Duffy Blood-Group System | 1 | 2011 | 6 | 0.370 |
Why?
| | Plasmodium vivax | 1 | 2011 | 4 | 0.370 |
Why?
| | Research Design | 4 | 2019 | 1107 | 0.370 |
Why?
| | Sequence Homology, Amino Acid | 5 | 2018 | 387 | 0.370 |
Why?
| | Extracellular Matrix Proteins | 1 | 2013 | 152 | 0.370 |
Why?
| | Transcription, Genetic | 2 | 2017 | 1453 | 0.370 |
Why?
| | Gene Frequency | 5 | 2011 | 520 | 0.360 |
Why?
| | Influenza, Human | 1 | 2017 | 624 | 0.360 |
Why?
| | Child | 21 | 2025 | 21968 | 0.360 |
Why?
| | Phenotype | 10 | 2023 | 3199 | 0.350 |
Why?
| | DNA, Viral | 1 | 2013 | 362 | 0.350 |
Why?
| | Flow Cytometry | 3 | 2024 | 1181 | 0.350 |
Why?
| | Receptors, Cell Surface | 2 | 2011 | 386 | 0.320 |
Why?
| | Protein Binding | 8 | 2019 | 2223 | 0.310 |
Why?
| | Models, Molecular | 5 | 2017 | 1591 | 0.310 |
Why?
| | Growth Disorders | 2 | 2020 | 86 | 0.310 |
Why?
| | Canada | 4 | 2025 | 420 | 0.300 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2011 | 429 | 0.300 |
Why?
| | Microcephaly | 2 | 2020 | 98 | 0.300 |
Why?
| | Mutation, Missense | 4 | 2023 | 338 | 0.300 |
Why?
| | Alleles | 5 | 2014 | 888 | 0.290 |
Why?
| | Facies | 4 | 2023 | 21 | 0.290 |
Why?
| | Sequence Alignment | 4 | 2019 | 345 | 0.280 |
Why?
| | A549 Cells | 2 | 2018 | 65 | 0.280 |
Why?
| | Epidemics | 2 | 2019 | 87 | 0.280 |
Why?
| | Child, Preschool | 15 | 2025 | 11069 | 0.280 |
Why?
| | Gene Duplication | 2 | 2021 | 68 | 0.270 |
Why?
| | Polymerase Chain Reaction | 4 | 2016 | 1059 | 0.270 |
Why?
| | DNA Transposable Elements | 2 | 2024 | 122 | 0.270 |
Why?
| | Viral Load | 2 | 2021 | 460 | 0.270 |
Why?
| | Saccharomyces | 1 | 2006 | 8 | 0.270 |
Why?
| | Molecular Diagnostic Techniques | 2 | 2021 | 104 | 0.270 |
Why?
| | Germ-Line Mutation | 4 | 2023 | 172 | 0.270 |
Why?
| | Haplotypes | 2 | 2005 | 490 | 0.260 |
Why?
| | Erythrocytes | 1 | 2011 | 692 | 0.250 |
Why?
| | Protein Structure, Tertiary | 6 | 2012 | 867 | 0.240 |
Why?
| | Genetics, Medical | 1 | 2025 | 26 | 0.240 |
Why?
| | Genotype | 6 | 2015 | 1919 | 0.240 |
Why?
| | Culicidae | 1 | 2025 | 35 | 0.240 |
Why?
| | Replication Origin | 2 | 2004 | 19 | 0.240 |
Why?
| | Neoplasms | 2 | 2022 | 2644 | 0.230 |
Why?
| | Genes, Viral | 4 | 2013 | 88 | 0.230 |
Why?
| | Receptor, Interferon alpha-beta | 1 | 2024 | 34 | 0.230 |
Why?
| | Nucleoside Deaminases | 1 | 2004 | 2 | 0.230 |
Why?
| | Aedes | 1 | 2025 | 65 | 0.230 |
Why?
| | Whole Genome Sequencing | 1 | 2025 | 152 | 0.220 |
Why?
| | Linkage Disequilibrium | 1 | 2005 | 268 | 0.220 |
Why?
| | Endogenous Retroviruses | 1 | 2005 | 36 | 0.220 |
Why?
| | Infant | 9 | 2025 | 9442 | 0.220 |
Why?
| | Musculoskeletal Abnormalities | 1 | 2024 | 13 | 0.220 |
Why?
| | DNA | 3 | 2004 | 1458 | 0.220 |
Why?
| | Carcinogenesis | 2 | 2016 | 217 | 0.220 |
Why?
| | Tooth Abnormalities | 1 | 2023 | 13 | 0.210 |
Why?
| | Nucleic Acid Hybridization | 2 | 2003 | 190 | 0.210 |
Why?
| | Bone Diseases, Developmental | 1 | 2023 | 15 | 0.210 |
Why?
| | Signal Transduction | 5 | 2024 | 5065 | 0.210 |
Why?
| | Codon, Terminator | 1 | 2003 | 25 | 0.210 |
Why?
| | Female | 27 | 2024 | 72840 | 0.210 |
Why?
| | Megalencephaly | 1 | 2023 | 20 | 0.210 |
Why?
| | Virion | 2 | 2021 | 90 | 0.210 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2016 | 151 | 0.210 |
Why?
| | Ontario | 4 | 2025 | 156 | 0.210 |
Why?
| | Cafe-au-Lait Spots | 1 | 2023 | 4 | 0.200 |
Why?
| | Vaginal Neoplasms | 1 | 2023 | 18 | 0.200 |
Why?
| | RNA Viruses | 2 | 2019 | 40 | 0.200 |
Why?
| | HIV | 1 | 2004 | 233 | 0.200 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2024 | 103 | 0.200 |
Why?
| | Triage | 1 | 2025 | 220 | 0.200 |
Why?
| | Developmental Disabilities | 3 | 2024 | 264 | 0.200 |
Why?
| | Alternative Splicing | 1 | 2024 | 227 | 0.200 |
Why?
| | Macaca | 1 | 2022 | 55 | 0.200 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2023 | 137 | 0.200 |
Why?
| | Mutagenesis, Insertional | 2 | 2018 | 65 | 0.200 |
Why?
| | Birds | 1 | 2023 | 89 | 0.190 |
Why?
| | Orthomyxoviridae Infections | 1 | 2023 | 75 | 0.190 |
Why?
| | Alzheimer Disease | 3 | 2003 | 557 | 0.190 |
Why?
| | Oligonucleotides | 1 | 2003 | 148 | 0.190 |
Why?
| | Mice | 10 | 2021 | 17731 | 0.190 |
Why?
| | Biomarkers | 2 | 2024 | 4158 | 0.190 |
Why?
| | Universities | 2 | 2023 | 432 | 0.190 |
Why?
| | Wilms Tumor | 1 | 2023 | 86 | 0.180 |
Why?
| | DNA Methylation | 2 | 2024 | 644 | 0.180 |
Why?
| | Asymptomatic Infections | 1 | 2021 | 27 | 0.180 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2021 | 36 | 0.180 |
Why?
| | Interferons | 2 | 2024 | 199 | 0.180 |
Why?
| | Pedigree | 4 | 2017 | 514 | 0.180 |
Why?
| | Ubiquitination | 2 | 2019 | 102 | 0.180 |
Why?
| | Viral Nonstructural Proteins | 2 | 2020 | 64 | 0.170 |
Why?
| | Monocytes | 1 | 2024 | 561 | 0.170 |
Why?
| | Glycosylation | 2 | 2019 | 163 | 0.170 |
Why?
| | Urinary Tract | 1 | 2021 | 51 | 0.170 |
Why?
| | Macaca mulatta | 2 | 2019 | 167 | 0.170 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2021 | 72 | 0.170 |
Why?
| | Fibroblasts | 2 | 2024 | 989 | 0.170 |
Why?
| | Genome-Wide Association Study | 3 | 2019 | 1434 | 0.170 |
Why?
| | Chromosome Disorders | 1 | 2021 | 43 | 0.170 |
Why?
| | Gene Expression Profiling | 2 | 2024 | 1768 | 0.170 |
Why?
| | Chromosomes, Human, X | 1 | 2021 | 74 | 0.170 |
Why?
| | Acute Disease | 1 | 2023 | 1006 | 0.170 |
Why?
| | Kidney Tubules | 1 | 2021 | 117 | 0.170 |
Why?
| | Blepharophimosis | 1 | 2020 | 3 | 0.170 |
Why?
| | Databases, Genetic | 3 | 2014 | 236 | 0.170 |
Why?
| | Crowdsourcing | 1 | 2020 | 18 | 0.170 |
Why?
| | Receptors, CCR5 | 2 | 2017 | 59 | 0.160 |
Why?
| | Eczema | 1 | 2020 | 69 | 0.160 |
Why?
| | DNA Primers | 2 | 2015 | 513 | 0.160 |
Why?
| | RNA Virus Infections | 1 | 2019 | 15 | 0.160 |
Why?
| | Specimen Handling | 1 | 2021 | 178 | 0.160 |
Why?
| | Pandemics | 3 | 2023 | 1619 | 0.160 |
Why?
| | Flavivirus Infections | 1 | 2019 | 9 | 0.160 |
Why?
| | env Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 16 | 0.160 |
Why?
| | RNA, Double-Stranded | 1 | 2019 | 57 | 0.160 |
Why?
| | HIV Envelope Protein gp120 | 1 | 2019 | 60 | 0.150 |
Why?
| | Models, Genetic | 4 | 2006 | 605 | 0.150 |
Why?
| | DNA Helicases | 1 | 2000 | 145 | 0.150 |
Why?
| | Cytidine Deaminase | 2 | 2013 | 61 | 0.150 |
Why?
| | Hemorrhagic Fever, Ebola | 1 | 2019 | 36 | 0.150 |
Why?
| | Histone Deacetylases | 1 | 2020 | 214 | 0.150 |
Why?
| | Viral Structural Proteins | 1 | 2018 | 12 | 0.150 |
Why?
| | Myofibromatosis | 1 | 2018 | 10 | 0.150 |
Why?
| | Male | 17 | 2024 | 67361 | 0.150 |
Why?
| | HIV Seropositivity | 1 | 2019 | 125 | 0.150 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2018 | 29 | 0.150 |
Why?
| | Alopecia | 1 | 2018 | 32 | 0.150 |
Why?
| | Nucleotidyltransferases | 1 | 2018 | 28 | 0.150 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2019 | 155 | 0.150 |
Why?
| | Sequence Homology | 1 | 2018 | 40 | 0.150 |
Why?
| | Kidney Neoplasms | 1 | 2023 | 400 | 0.140 |
Why?
| | DEAD Box Protein 58 | 1 | 2017 | 9 | 0.140 |
Why?
| | DNA, Fungal | 1 | 2018 | 79 | 0.140 |
Why?
| | Africa | 1 | 2018 | 108 | 0.140 |
Why?
| | SUMO-1 Protein | 1 | 2017 | 21 | 0.140 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2019 | 144 | 0.140 |
Why?
| | Acetyltransferases | 1 | 2017 | 22 | 0.140 |
Why?
| | Charcot-Marie-Tooth Disease | 1 | 2017 | 21 | 0.140 |
Why?
| | Hylobates | 1 | 2016 | 8 | 0.130 |
Why?
| | Pongo | 1 | 2016 | 6 | 0.130 |
Why?
| | Infant, Newborn | 4 | 2018 | 6046 | 0.130 |
Why?
| | Pathology, Molecular | 1 | 2017 | 27 | 0.130 |
Why?
| | Callithrix | 1 | 2016 | 12 | 0.130 |
Why?
| | Membrane Transport Proteins | 1 | 2018 | 162 | 0.130 |
Why?
| | Intelligence | 1 | 2017 | 130 | 0.130 |
Why?
| | Totivirus | 1 | 2016 | 1 | 0.130 |
Why?
| | RNA-Binding Proteins | 1 | 2021 | 424 | 0.130 |
Why?
| | Behavior Therapy | 1 | 2019 | 257 | 0.130 |
Why?
| | Young Adult | 7 | 2021 | 13126 | 0.130 |
Why?
| | Chondroblastoma | 1 | 2016 | 3 | 0.130 |
Why?
| | Brachydactyly | 1 | 2016 | 1 | 0.130 |
Why?
| | Dysarthria | 1 | 2016 | 10 | 0.130 |
Why?
| | Spinocerebellar Ataxias | 1 | 2016 | 6 | 0.130 |
Why?
| | Immunoprecipitation | 1 | 2016 | 155 | 0.130 |
Why?
| | Spastic Paraplegia, Hereditary | 1 | 2016 | 12 | 0.130 |
Why?
| | Immunoblotting | 1 | 2016 | 307 | 0.130 |
Why?
| | Receptors, Immunologic | 1 | 2017 | 217 | 0.130 |
Why?
| | Adult | 9 | 2019 | 37616 | 0.130 |
Why?
| | Genetic Association Studies | 2 | 2015 | 376 | 0.130 |
Why?
| | Capsid | 3 | 2012 | 93 | 0.130 |
Why?
| | Filoviridae | 1 | 2015 | 6 | 0.130 |
Why?
| | Autism Spectrum Disorder | 2 | 2021 | 392 | 0.120 |
Why?
| | Cell Differentiation | 1 | 2024 | 1980 | 0.120 |
Why?
| | Sensitivity and Specificity | 1 | 2021 | 1942 | 0.120 |
Why?
| | Peptide Chain Elongation, Translational | 1 | 2015 | 18 | 0.120 |
Why?
| | Protein Interaction Mapping | 1 | 2016 | 109 | 0.120 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2016 | 376 | 0.120 |
Why?
| | Immunity, Innate | 3 | 2024 | 826 | 0.120 |
Why?
| | Antiviral Agents | 2 | 2021 | 736 | 0.120 |
Why?
| | White Matter | 1 | 2017 | 145 | 0.120 |
Why?
| | Muscle Spasticity | 1 | 2016 | 58 | 0.120 |
Why?
| | Disease Resistance | 1 | 2015 | 33 | 0.120 |
Why?
| | Myositis Ossificans | 1 | 2015 | 3 | 0.120 |
Why?
| | Activin Receptors, Type I | 1 | 2015 | 7 | 0.120 |
Why?
| | Hallux Valgus | 1 | 2015 | 9 | 0.120 |
Why?
| | Heat-Shock Proteins | 1 | 2016 | 142 | 0.120 |
Why?
| | Tuberculosis | 1 | 2018 | 279 | 0.120 |
Why?
| | Neanderthals | 1 | 2015 | 13 | 0.120 |
Why?
| | Molecular Docking Simulation | 1 | 2015 | 112 | 0.120 |
Why?
| | Fanconi Anemia Complementation Group Proteins | 1 | 2014 | 6 | 0.120 |
Why?
| | Blotting, Western | 2 | 2016 | 1225 | 0.120 |
Why?
| | Extinction, Biological | 1 | 2015 | 36 | 0.110 |
Why?
| | Vesicle-Associated Membrane Protein 1 | 1 | 2014 | 2 | 0.110 |
Why?
| | Craniofacial Abnormalities | 1 | 2015 | 72 | 0.110 |
Why?
| | Gene Expression | 2 | 2011 | 1499 | 0.110 |
Why?
| | HIV-2 | 1 | 2014 | 18 | 0.110 |
Why?
| | Colorado | 2 | 2023 | 4491 | 0.110 |
Why?
| | Acclimatization | 1 | 2016 | 176 | 0.110 |
Why?
| | Monomeric GTP-Binding Proteins | 1 | 2014 | 11 | 0.110 |
Why?
| | Adolescent | 9 | 2021 | 21463 | 0.110 |
Why?
| | Syndrome | 1 | 2015 | 357 | 0.110 |
Why?
| | Morphogenesis | 1 | 2015 | 166 | 0.110 |
Why?
| | Transfection | 1 | 2016 | 945 | 0.110 |
Why?
| | Ribosomes | 1 | 2015 | 185 | 0.110 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 219 | 0.110 |
Why?
| | Siblings | 1 | 2015 | 228 | 0.110 |
Why?
| | Gene Rearrangement | 1 | 2015 | 149 | 0.110 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2017 | 455 | 0.110 |
Why?
| | Hemiplegia | 1 | 2014 | 21 | 0.110 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2015 | 106 | 0.110 |
Why?
| | Magnetic Resonance Imaging | 2 | 2017 | 3566 | 0.110 |
Why?
| | Chromosome Mapping | 3 | 2005 | 523 | 0.110 |
Why?
| | Consanguinity | 1 | 2014 | 49 | 0.110 |
Why?
| | Dystonic Disorders | 1 | 2014 | 25 | 0.110 |
Why?
| | Botulinum Toxins | 1 | 2014 | 41 | 0.110 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2014 | 49 | 0.110 |
Why?
| | Colorectal Neoplasms | 1 | 2021 | 792 | 0.110 |
Why?
| | Peer Review, Research | 1 | 2014 | 43 | 0.110 |
Why?
| | Sarcoma | 1 | 2016 | 191 | 0.110 |
Why?
| | Bone Neoplasms | 1 | 2016 | 248 | 0.100 |
Why?
| | Gene Library | 1 | 2013 | 117 | 0.100 |
Why?
| | Chromosomal Proteins, Non-Histone | 3 | 2004 | 126 | 0.100 |
Why?
| | Membrane Glycoproteins | 1 | 2015 | 500 | 0.100 |
Why?
| | Adaptation, Biological | 1 | 2013 | 56 | 0.100 |
Why?
| | Nervous System Malformations | 1 | 2013 | 42 | 0.100 |
Why?
| | Mass Screening | 1 | 2021 | 1262 | 0.100 |
Why?
| | Amphibians | 1 | 2013 | 53 | 0.100 |
Why?
| | Parvovirus, Canine | 1 | 2012 | 1 | 0.100 |
Why?
| | Canidae | 1 | 2012 | 1 | 0.100 |
Why?
| | Parvoviridae Infections | 1 | 2012 | 12 | 0.100 |
Why?
| | Brain | 3 | 2015 | 2669 | 0.100 |
Why?
| | DNA Mutational Analysis | 4 | 2014 | 400 | 0.100 |
Why?
| | mRNA Cleavage and Polyadenylation Factors | 1 | 2012 | 29 | 0.090 |
Why?
| | Neoplastic Stem Cells | 1 | 2016 | 397 | 0.090 |
Why?
| | Neoplasm Recurrence, Local | 3 | 2023 | 1055 | 0.090 |
Why?
| | Cluster Analysis | 1 | 2013 | 495 | 0.090 |
Why?
| | Family Health | 1 | 2012 | 197 | 0.090 |
Why?
| | Chordata | 1 | 2011 | 5 | 0.090 |
Why?
| | Endoribonucleases | 2 | 2022 | 80 | 0.090 |
Why?
| | Middle Aged | 5 | 2017 | 33200 | 0.090 |
Why?
| | Observational Studies as Topic | 2 | 2022 | 116 | 0.090 |
Why?
| | Hospitalization | 1 | 2021 | 2195 | 0.090 |
Why?
| | Gene Dosage | 1 | 2011 | 144 | 0.090 |
Why?
| | Retroviridae Infections | 2 | 2009 | 46 | 0.090 |
Why?
| | DNA Polymerase beta | 1 | 2010 | 5 | 0.090 |
Why?
| | Iron | 1 | 2013 | 311 | 0.090 |
Why?
| | Biomarkers, Tumor | 3 | 2022 | 1274 | 0.090 |
Why?
| | Endonucleases | 1 | 2010 | 32 | 0.090 |
Why?
| | Multicenter Studies as Topic | 2 | 2022 | 307 | 0.090 |
Why?
| | Protein Structure, Secondary | 1 | 2011 | 376 | 0.080 |
Why?
| | DNA Breaks, Double-Stranded | 1 | 2010 | 43 | 0.080 |
Why?
| | Lung | 1 | 2023 | 4065 | 0.080 |
Why?
| | Epilepsy | 1 | 2014 | 332 | 0.080 |
Why?
| | Endodeoxyribonucleases | 1 | 2010 | 71 | 0.080 |
Why?
| | Prospective Studies | 4 | 2023 | 7583 | 0.080 |
Why?
| | Gene Conversion | 1 | 1989 | 7 | 0.080 |
Why?
| | Vero Cells | 2 | 2019 | 67 | 0.080 |
Why?
| | Genetic Techniques | 1 | 1989 | 64 | 0.080 |
Why?
| | Fetal Growth Retardation | 1 | 2015 | 565 | 0.080 |
Why?
| | Rodentia | 1 | 2009 | 56 | 0.080 |
Why?
| | Disease Models, Animal | 1 | 2019 | 4279 | 0.070 |
Why?
| | Statistics as Topic | 1 | 1989 | 311 | 0.070 |
Why?
| | Pregnancy | 1 | 2021 | 6731 | 0.070 |
Why?
| | Survival Rate | 1 | 2013 | 1969 | 0.070 |
Why?
| | Estrogens | 1 | 2011 | 367 | 0.070 |
Why?
| | Chromosome Deletion | 2 | 2021 | 115 | 0.070 |
Why?
| | Reverse Transcription | 1 | 2007 | 19 | 0.070 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2025 | 1455 | 0.070 |
Why?
| | Algorithms | 1 | 2015 | 1686 | 0.070 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2007 | 48 | 0.070 |
Why?
| | Cell Line, Tumor | 1 | 2015 | 3399 | 0.070 |
Why?
| | Binding Sites | 1 | 2010 | 1308 | 0.070 |
Why?
| | Minichromosome Maintenance Proteins | 2 | 2004 | 5 | 0.070 |
Why?
| | Genetics, Population | 2 | 2006 | 210 | 0.070 |
Why?
| | Adaptation, Physiological | 1 | 2010 | 546 | 0.060 |
Why?
| | Meiosis | 1 | 2006 | 81 | 0.060 |
Why?
| | Genomic Instability | 1 | 2006 | 53 | 0.060 |
Why?
| | Students | 2 | 2023 | 624 | 0.060 |
Why?
| | Cattle | 1 | 2007 | 981 | 0.060 |
Why?
| | Point Mutation | 2 | 2018 | 234 | 0.060 |
Why?
| | Chromosomes, Human, Pair 10 | 1 | 2004 | 19 | 0.060 |
Why?
| | vif Gene Products, Human Immunodeficiency Virus | 1 | 2004 | 3 | 0.060 |
Why?
| | APOBEC-1 Deaminase | 1 | 2004 | 5 | 0.060 |
Why?
| | APOBEC-3G Deaminase | 1 | 2004 | 6 | 0.060 |
Why?
| | APOBEC Deaminases | 1 | 2004 | 6 | 0.060 |
Why?
| | Gene Products, vif | 1 | 2004 | 2 | 0.060 |
Why?
| | Cats | 2 | 2019 | 209 | 0.060 |
Why?
| | Limb Deformities, Congenital | 1 | 2024 | 14 | 0.060 |
Why?
| | RNA Editing | 1 | 2004 | 24 | 0.060 |
Why?
| | T-Lymphocytes | 1 | 2013 | 1998 | 0.060 |
Why?
| | Genomic Structural Variation | 1 | 2024 | 12 | 0.050 |
Why?
| | Minichromosome Maintenance Complex Component 7 | 2 | 2000 | 4 | 0.050 |
Why?
| | Muscle Hypotonia | 1 | 2024 | 33 | 0.050 |
Why?
| | Likelihood Functions | 1 | 2004 | 142 | 0.050 |
Why?
| | rab5 GTP-Binding Proteins | 1 | 2023 | 8 | 0.050 |
Why?
| | Catalysis | 1 | 2004 | 316 | 0.050 |
Why?
| | False Positive Reactions | 1 | 2003 | 114 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2024 | 400 | 0.050 |
Why?
| | Plant Viruses | 1 | 2003 | 7 | 0.050 |
Why?
| | rab GTP-Binding Proteins | 1 | 2023 | 75 | 0.050 |
Why?
| | Sequence Deletion | 1 | 2003 | 183 | 0.050 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2004 | 232 | 0.050 |
Why?
| | Neuroblastoma | 1 | 2024 | 160 | 0.050 |
Why?
| | Muscle Proteins | 1 | 2004 | 229 | 0.050 |
Why?
| | Monkeypox virus | 1 | 2022 | 16 | 0.050 |
Why?
| | Risk Factors | 3 | 2012 | 10331 | 0.050 |
Why?
| | Cost-Benefit Analysis | 1 | 2025 | 584 | 0.050 |
Why?
| | Genetic Markers | 1 | 2003 | 344 | 0.050 |
Why?
| | Focus Groups | 1 | 2025 | 508 | 0.050 |
Why?
| | Masks | 1 | 2023 | 62 | 0.050 |
Why?
| | Cytoplasm | 1 | 2022 | 271 | 0.050 |
Why?
| | Arachis | 1 | 2003 | 112 | 0.050 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2022 | 107 | 0.040 |
Why?
| | Neuroimaging | 1 | 2023 | 263 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2003 | 765 | 0.040 |
Why?
| | Minichromosome Maintenance Complex Component 4 | 1 | 2000 | 1 | 0.040 |
Why?
| | Minichromosome Maintenance Complex Component 3 | 1 | 2000 | 2 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2024 | 618 | 0.040 |
Why?
| | Attitude | 1 | 2023 | 259 | 0.040 |
Why?
| | Haploinsufficiency | 1 | 2021 | 56 | 0.040 |
Why?
| | Oligopeptides | 1 | 2022 | 272 | 0.040 |
Why?
| | Dimerization | 1 | 2000 | 198 | 0.040 |
Why?
| | Knowledge Bases | 1 | 2020 | 27 | 0.040 |
Why?
| | B-Lymphocytes | 1 | 2006 | 846 | 0.040 |
Why?
| | Geminiviridae | 1 | 1999 | 1 | 0.040 |
Why?
| | Caenorhabditis elegans | 1 | 2023 | 305 | 0.040 |
Why?
| | Immunologic Factors | 1 | 2022 | 237 | 0.040 |
Why?
| | Catalytic Domain | 1 | 2000 | 226 | 0.040 |
Why?
| | Referral and Consultation | 1 | 2025 | 777 | 0.040 |
Why?
| | DNA Copy Number Variations | 1 | 2020 | 182 | 0.040 |
Why?
| | Histone Acetyltransferases | 1 | 2020 | 60 | 0.040 |
Why?
| | Flavivirus | 1 | 2019 | 18 | 0.040 |
Why?
| | Retrospective Studies | 2 | 2014 | 15564 | 0.040 |
Why?
| | Disease Outbreaks | 1 | 2022 | 382 | 0.040 |
Why?
| | Zebrafish | 1 | 2023 | 495 | 0.040 |
Why?
| | Cloning, Molecular | 2 | 2011 | 534 | 0.040 |
Why?
| | Skull | 1 | 2020 | 139 | 0.040 |
Why?
| | Philippines | 1 | 2018 | 51 | 0.040 |
Why?
| | HeLa Cells | 1 | 2000 | 636 | 0.040 |
Why?
| | Nucleotides, Cyclic | 1 | 2018 | 17 | 0.040 |
Why?
| | Proteolysis | 1 | 2019 | 178 | 0.040 |
Why?
| | Substrate Specificity | 1 | 2019 | 384 | 0.040 |
Why?
| | Genes, Recessive | 1 | 2018 | 78 | 0.040 |
Why?
| | DNA Replication | 1 | 2000 | 238 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2003 | 2030 | 0.040 |
Why?
| | Age Distribution | 1 | 2018 | 391 | 0.040 |
Why?
| | Capsid Proteins | 2 | 2012 | 94 | 0.030 |
Why?
| | Encephalitis, Viral | 1 | 1997 | 43 | 0.030 |
Why?
| | Immunotherapy | 1 | 2022 | 640 | 0.030 |
Why?
| | Developing Countries | 1 | 2019 | 306 | 0.030 |
Why?
| | Herpes Simplex | 1 | 1997 | 92 | 0.030 |
Why?
| | Pilot Projects | 1 | 2022 | 1697 | 0.030 |
Why?
| | Langer-Giedion Syndrome | 1 | 2016 | 2 | 0.030 |
Why?
| | Hair Diseases | 1 | 2016 | 9 | 0.030 |
Why?
| | Cycloheximide | 1 | 2015 | 55 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2021 | 658 | 0.030 |
Why?
| | Nose | 1 | 2016 | 67 | 0.030 |
Why?
| | Dendritic Cells | 1 | 2019 | 484 | 0.030 |
Why?
| | Polycomb Repressive Complex 1 | 1 | 2016 | 50 | 0.030 |
Why?
| | Fingers | 1 | 2016 | 88 | 0.030 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2015 | 47 | 0.030 |
Why?
| | Methylation | 1 | 2016 | 231 | 0.030 |
Why?
| | Codon | 1 | 2015 | 89 | 0.030 |
Why?
| | Guanylate Kinases | 1 | 2015 | 13 | 0.030 |
Why?
| | Methyltransferases | 1 | 2016 | 78 | 0.030 |
Why?
| | Tooth, Deciduous | 1 | 2015 | 18 | 0.030 |
Why?
| | Chromosomes, Human, Pair 2 | 1 | 2015 | 29 | 0.030 |
Why?
| | Methionine | 1 | 2016 | 159 | 0.030 |
Why?
| | Incisor | 1 | 2015 | 18 | 0.030 |
Why?
| | Population Surveillance | 1 | 2018 | 470 | 0.030 |
Why?
| | Genome, Mitochondrial | 1 | 2015 | 28 | 0.030 |
Why?
| | Dental Enamel | 1 | 2015 | 70 | 0.030 |
Why?
| | Archaeology | 1 | 2015 | 39 | 0.030 |
Why?
| | Machine Learning | 1 | 2020 | 487 | 0.030 |
Why?
| | Multiplex Polymerase Chain Reaction | 1 | 2015 | 54 | 0.030 |
Why?
| | RNA, Transfer | 1 | 2015 | 138 | 0.030 |
Why?
| | Thyroid Gland | 1 | 2015 | 94 | 0.030 |
Why?
| | Paresis | 1 | 2014 | 30 | 0.030 |
Why?
| | Deoxyribonucleotides | 1 | 2014 | 19 | 0.030 |
Why?
| | Diaphragm | 1 | 2014 | 42 | 0.030 |
Why?
| | Myopathies, Structural, Congenital | 1 | 2014 | 6 | 0.030 |
Why?
| | SAM Domain and HD Domain-Containing Protein 1 | 1 | 2014 | 11 | 0.030 |
Why?
| | Fatal Outcome | 1 | 2015 | 304 | 0.030 |
Why?
| | Mice, Knockout | 2 | 2018 | 2999 | 0.030 |
Why?
| | Nucleosomes | 1 | 2016 | 155 | 0.030 |
Why?
| | Interferon-gamma | 1 | 1997 | 790 | 0.030 |
Why?
| | Long Interspersed Nucleotide Elements | 1 | 2014 | 30 | 0.030 |
Why?
| | Financing, Organized | 1 | 2014 | 35 | 0.030 |
Why?
| | Prognosis | 1 | 2022 | 4018 | 0.030 |
Why?
| | Uterus | 1 | 2015 | 215 | 0.030 |
Why?
| | Lysine | 1 | 2016 | 293 | 0.030 |
Why?
| | DNA, Mitochondrial | 1 | 2015 | 200 | 0.030 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 1683 | 0.030 |
Why?
| | Time Factors | 1 | 2004 | 6792 | 0.030 |
Why?
| | RING Finger Domains | 1 | 2013 | 4 | 0.030 |
Why?
| | Brain Diseases | 1 | 2014 | 141 | 0.030 |
Why?
| | Meta-Analysis as Topic | 1 | 2014 | 172 | 0.030 |
Why?
| | Cytokines | 1 | 2021 | 2088 | 0.030 |
Why?
| | Rats | 2 | 2014 | 5628 | 0.030 |
Why?
| | Loss of Heterozygosity | 1 | 2013 | 51 | 0.030 |
Why?
| | Receptors, CXCR4 | 1 | 2013 | 85 | 0.020 |
Why?
| | Risk | 1 | 2015 | 904 | 0.020 |
Why?
| | Transferrin | 1 | 2012 | 46 | 0.020 |
Why?
| | Cell Transformation, Viral | 1 | 1992 | 26 | 0.020 |
Why?
| | CHO Cells | 1 | 2012 | 160 | 0.020 |
Why?
| | Motor Neurons | 1 | 2014 | 234 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2013 | 309 | 0.020 |
Why?
| | Penetrance | 1 | 2011 | 28 | 0.020 |
Why?
| | Cricetinae | 1 | 2012 | 288 | 0.020 |
Why?
| | Erythropoiesis | 1 | 1992 | 54 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 5417 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2012 | 225 | 0.020 |
Why?
| | Aromatase | 1 | 2011 | 32 | 0.020 |
Why?
| | Erythropoietin | 1 | 1992 | 95 | 0.020 |
Why?
| | DNA, Complementary | 1 | 2011 | 269 | 0.020 |
Why?
| | Mice, Inbred C57BL | 2 | 2018 | 5744 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2016 | 1396 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4194 | 0.020 |
Why?
| | Crystallography, X-Ray | 1 | 2011 | 485 | 0.020 |
Why?
| | Genes, Bacterial | 1 | 1989 | 165 | 0.020 |
Why?
| | Models, Statistical | 2 | 2004 | 658 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2014 | 2481 | 0.020 |
Why?
| | Apoptosis | 1 | 1997 | 2548 | 0.020 |
Why?
| | Neurons | 1 | 1997 | 1583 | 0.020 |
Why?
| | Hematopoietic Stem Cells | 1 | 1992 | 400 | 0.020 |
Why?
| | Family | 1 | 2013 | 666 | 0.020 |
Why?
| | Receptors, Estrogen | 1 | 2011 | 436 | 0.020 |
Why?
| | Comorbidity | 1 | 2011 | 1611 | 0.020 |
Why?
| | Heart Defects, Congenital | 1 | 2014 | 831 | 0.020 |
Why?
| | Expressed Sequence Tags | 1 | 2006 | 42 | 0.020 |
Why?
| | Escherichia coli | 1 | 1989 | 812 | 0.010 |
Why?
| | Aged | 2 | 2015 | 23729 | 0.010 |
Why?
| | Cohort Studies | 1 | 2014 | 5718 | 0.010 |
Why?
| | Africa, Western | 1 | 2003 | 17 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 1989 | 895 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2015 | 7569 | 0.010 |
Why?
| | India | 1 | 2003 | 193 | 0.010 |
Why?
| | Open Reading Frames | 1 | 2003 | 119 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2003 | 240 | 0.010 |
Why?
| | Sweden | 1 | 2001 | 101 | 0.010 |
Why?
| | Sample Size | 1 | 2001 | 117 | 0.010 |
Why?
| | Genetic Linkage | 1 | 2001 | 298 | 0.010 |
Why?
| | Two-Hybrid System Techniques | 1 | 2000 | 59 | 0.010 |
Why?
| | Crosses, Genetic | 1 | 2000 | 137 | 0.010 |
Why?
| | G1 Phase | 1 | 2000 | 71 | 0.010 |
Why?
| | Gene Deletion | 1 | 2001 | 392 | 0.010 |
Why?
| | Plasmids | 1 | 2000 | 362 | 0.010 |
Why?
| | Cell Cycle | 1 | 2000 | 601 | 0.010 |
Why?
| | Antigens, Viral | 1 | 1997 | 180 | 0.010 |
Why?
| | Interleukin-4 | 1 | 1997 | 217 | 0.010 |
Why?
| | Temperature | 1 | 2000 | 674 | 0.010 |
Why?
| | Eye | 1 | 1997 | 108 | 0.010 |
Why?
| | Chromatin | 1 | 2000 | 518 | 0.010 |
Why?
| | Defective Viruses | 1 | 1992 | 5 | 0.010 |
Why?
| | Interleukin-3 | 1 | 1992 | 25 | 0.010 |
Why?
| | Receptors, Erythropoietin | 1 | 1992 | 20 | 0.010 |
Why?
| | Gene Expression Regulation, Viral | 1 | 1992 | 92 | 0.010 |
Why?
| | Fluorouracil | 1 | 1992 | 210 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 1992 | 663 | 0.000 |
Why?
| | Inflammation | 1 | 1997 | 2834 | 0.000 |
Why?
|
|
Sawyer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|